ADC Therapeutics S.A.
ADCT · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $251 | $279 | $326 | $467 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $20 | $25 | $73 | $32 |
| Inventory | $18 | $16 | $12 | $11 |
| Other Curr. Assets | $18 | $16 | $23 | $15 |
| Total Curr. Assets | $307 | $336 | $435 | $525 |
| Property Plant & Equip (Net) | $13 | $16 | $10 | $11 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $14 | $14 |
| Long-Term Investments | $0 | $2 | $8 | $41 |
| Tax Assets | $0 | $0 | $37 | $26 |
| Other NC Assets | $1 | $1 | -$13 | $1 |
| Total NC Assets | $15 | $18 | $56 | $93 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $322 | $355 | $491 | $618 |
| Liabilities | – | – | – | – |
| Payables | $18 | $16 | $12 | $12 |
| Short-Term Debt | $1 | $1 | $14 | $8 |
| Tax Payable | $0 | $0 | $0 | $4 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $61 | $51 | $56 | $50 |
| Total Curr. Liab. | $80 | $68 | $82 | $74 |
| LT Debt | $122 | $123 | $116 | $132 |
| Deferred Rev, NC | $320 | $0 | $24 | $24 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $312 | $190 | $222 |
| Total NC Liab. | $444 | $435 | $329 | $378 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $12 | $8 | $8 |
| Total Liabilities | $525 | $503 | $411 | $452 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8 | $7 | $7 | $6 |
| Retained Earnings | -$1,493 | -$1,335 | -$1,095 | -$925 |
| AOCI | -$1 | -$0 | $2 | $103 |
| Other Equity | $1,284 | $1,180 | $1,166 | $982 |
| Total Equity | -$203 | -$148 | $79 | $166 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $322 | $355 | $491 | $618 |
| Net Debt | -$128 | -$154 | -$197 | -$327 |